tirzepatide cvot In patients with type 2 diabetes and atherosclerotic cardiovascular disease, was noninferior to dulaglutide with respect to major cardiovascular events. Full SURPASS-CVOT trial results: https://nej.md/4qd5rLx 🫀 EASD 2025: Tirzepatide (SURPASS-CVOT)

See section When should you be careful when using Wegovy Multi FixDose? for information on the increased risk of hypoglycaemia and the section What side effects can Wegovy Multi FixDose have? about the warning signs of hypoglycemia

When lean mass is lost during weight reduction, energy requirements decrease, which may make weight regain more likely

Research Handling Guidance In published research protocols, BAC water is typically added to lyophilised peptide vials in controlled volumes, with the vial swirled gently not shaken until fully dissolved

It may be beneficial to speak to a dermatologist before commencing Ozempic treatment

Each pack of Wegovy 0.5 mg contains: 1 Pre-filled pen with 4 weekly doses

Autophagy and tubular cell death in the kidney